 |
| WEAP is officially approved by
Dr. Lovaas. |
 |
After
directing an inpatient program for children with autism in Wisconsin
for 14 years, Dr. Glen Sallows studied with Dr. Ivar
Lovaas at UCLA to obtain advanced training in the intensive behavioral
treatment approach (Applied Behavior Analysis) for children with
autism. Tamlynn Graupner also studied with Dr. Lovaas to learn
effective strategies for evaluating children with autism. In 1995,
after completing this intensive training, Dr. Sallows and Ms. Graupner
co-founded the Wisconsin Early Autism Project and began offering the treatment
to families in Wisconsin and other areas.
Since 1995, WEAP has grown to serve
hundreds
of families in Wisconsin and other states. The
organization has expanded
to offer clinical
services through Early Autism Projects in London, Vancouver B.C.
, and Australia, allowing this research-driven program to reach
hundreds of children across several continents.
WEAP is one of several replication research sites approved by
Dr. Lovaas, and the first to achieve outcomes that match Lovaas'
original study. Dr. Sallows continues to study the effects of ABA
treatment and participates in ongoing research as part of a worldwide
effort.
WEAP provides the same effective treatment as that offered by Dr. Lovaas' UCLA
Clinic and is committed to making it available to as many children as possible.
WEAP's goal is to improve outcomes and positively impact the lives of children
challenged by autism and the families who love them.
For more information about how to apply for funding
and services in your county, please call our Intake Department at
608-288-9040, send an e-mail to weap@wiautism.com,
or complete the online form to contact
us today. |
|